000			01787 a2200493 4500
005			20250514015051.0
264		0	_c20011214
008			200112s 0 0 eng d
022			_a1098-4275
024	7		_a10.1542/peds.108.5.e81 _2doi
040			_aNLM _beng _cNLM
100	1		_aSalmaso, S
245	0	0	_aSustained efficacy during the first 6 years of life of 3-component acellular pertussis vaccines administered in infancy: the Italian experience. _h[electronic resource]
260			_bPediatrics _cNov 2001
300			_aE81 p. _bdigital
500			_aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aAge Factors
650	0	4	_aAntibodies, Bacterial _xblood
650	0	4	_aBordetella pertussis _ximmunology
650	0	4	_aChild
650	0	4	_aChild, Preschool
650	0	4	_aDiphtheria-Tetanus-Pertussis Vaccine _xadministration & dosage
650	0	4	_aDiphtheria-Tetanus-acellular Pertussis Vaccines _xadministration & dosage
650	0	4	_aDouble-Blind Method
650	0	4	_aFemale
650	0	4	_aFollow-Up Studies
650	0	4	_aHumans
650	0	4	_aImmunization Schedule
650	0	4	_aImmunoglobulin A _xblood
650	0	4	_aImmunoglobulin G _xblood
650	0	4	_aIncidence
650	0	4	_aItaly _xepidemiology
650	0	4	_aMale
650	0	4	_aPopulation Surveillance
650	0	4	_aWhooping Cough _xepidemiology
700	1		_aMastrantonio, P
700	1		_aTozzi, A E
700	1		_aStefanelli, P
700	1		_aAnemona, A
700	1		_aCiofi degli Atti, M L
700	1		_aGiammanco, A
773	0		_tPediatrics _gvol. 108 _gno. 5 _gp. E81
856	4	0	_uhttps://doi.org/10.1542/peds.108.5.e81 _zAvailable from publisher's website
999			_c11610263 _d11610263